PRELUDE CAPITAL MANAGEMENT, LLC - AEGERION PHARMACEUTICALS INC ownership

AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 19 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AEGERION PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$116,000
+12.6%
200,0000.0%0.02%
+14.3%
Q1 2016$103,000
-23.1%
200,0000.0%0.01%
-33.3%
Q4 2015$134,000
-11.3%
200,0000.0%0.02%
-4.5%
Q3 2015$151,000200,0000.02%
Other shareholders
AEGERION PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Context Capital Management, LLC 1,760,000$898,0001.12%
Telemetry Investments, L.L.C. 6,000,000$3,049,0000.89%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 54,500,000$27,693,0000.46%
ZAZOVE ASSOCIATES LLC 15,070,000$7,761,0000.37%
ACUTA CAPITAL PARTNERS, LLC 1,000,000$508,0000.28%
Tekla Capital Management LLC 13,000,000$6,606,0000.28%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 26,000,000$13,910,000,0000.26%
Castle Creek Arbitrage, LLC 4,000,000$2,081,0000.17%
WOLVERINE ASSET MANAGEMENT LLC 10,934,000$5,558,0000.16%
Baker Brothers Advisors 26,517,000$13,526,0000.14%
View complete list of AEGERION PHARMACEUTICALS INC shareholders